Brief: CSL Says Neffy, Adrenaline Nasal Spray, Approved To Treat Anaphylaxis In Australia
16/02/2026 01:57
Feb 16 (Reuters) - CSL Ltd CSL.AX: NEFFY, ADRENALINE NASAL SPRAY, NOW APPROVED TO TREAT ANAPHYLAXIS IN AUSTRALIA Further company coverage: CSL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CSL
See all newsAustralia's CSL faces investor proceeding over disclosure obligations (updated)
Australia's CSL faces investor proceeding over disclosure obligations
Citi says CSL's CEO pick brings key strengths
Australia's CSL names GSK executive Waterhouse as next CEO (updated)
Brief: CSL Limited Appoints Deborah Waterhouse As CEO And Managing Director